Ainos Inc (AIMD)

$0.81011

-0.03

(-3.15%)▲

Live

Insights on Ainos Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 19.90K → 20.72K (in $), with an average increase of 4.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -5.92M → -3.31M (in $), with an average increase of 78.7% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 45.7% return, outperforming this stock by 121.6%

Performance

  • $0.77
    $0.84
    $0.81
    downward going graph

    4.33%

    Downside

    Day's Volatility :7.74%

    Upside

    3.56%

    downward going graph
  • $0.79
    $6.10
    $0.81
    downward going graph

    2.47%

    Downside

    52 Weeks Volatility :87.05%

    Upside

    86.72%

    downward going graph

Returns

PeriodAinos IncIndex (Russel 2000)
3 Months
-41.09%
0.0%
6 Months
-70.9%
0.0%
1 Year
-75.75%
0.0%
3 Years
-98.67%
-22.6%

Highlights

Market Capitalization
5.5M
Book Value
$3.69
Earnings Per Share (EPS)
-3.3
Profit Margin
0.0%
Operating Margin TTM
-15051.82%
Return On Assets TTM
-25.44%
Return On Equity TTM
-52.95%
Revenue TTM
93.7K
Revenue Per Share TTM
0.02
Quarterly Revenue Growth YOY
-57.8%
Gross Profit TTM
410.4K
EBITDA
-8.7M
Diluted Eps TTM
-3.3
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY18Y/Y Change
Revenue
77.7K
↓ 69.03%
Net Income
-1.3M
↑ 116.83%
Net Profit Margin
-1.7K%
↓ 1476.26%
FY19Y/Y Change
Revenue
11.7K
↓ 84.91%
Net Income
-1.6M
↑ 18.19%
Net Profit Margin
-13.5K%
↓ 11764.9%
FY20Y/Y Change
Revenue
16.6K
↑ 41.19%
Net Income
-1.5M
↓ 7.67%
Net Profit Margin
-8.8K%
↑ 4667.48%
FY21Y/Y Change
Revenue
594.6K
↑ 3489.71%
Net Income
-3.9M
↑ 167.3%
Net Profit Margin
-656.75%
↑ 8162.97%
FY22Y/Y Change
Revenue
3.5M
↑ 491.97%
Net Income
-14.0M
↑ 259.48%
Net Profit Margin
-398.83%
↑ 257.92%
FY23Y/Y Change
Revenue
122.1K
↓ 96.53%
Net Income
-13.8M
↓ 1.9%
Net Profit Margin
-11.3K%
↓ 10878.15%
Q4 FY22Q/Q Change
Revenue
1.0M
↓ 40.95%
Net Income
-2.1M
↓ 72.75%
Net Profit Margin
-205.29%
↑ 239.66%
Q1 FY23Q/Q Change
Revenue
1.0M
↑ 0.0%
Net Income
-2.1M
↑ 0.21%
Net Profit Margin
-205.72%
↓ 0.43%
Q2 FY23Q/Q Change
Revenue
28.6K
↓ 97.25%
Net Income
-2.3M
↑ 10.04%
Net Profit Margin
-8.2K%
↓ 8023.06%
Q3 FY23Q/Q Change
Revenue
24.5K
↓ 14.24%
Net Income
-3.0M
↑ 26.65%
Net Profit Margin
-12.2K%
↓ 3922.99%
Q4 FY23Q/Q Change
Revenue
19.9K
↓ 18.72%
Net Income
-5.9M
↑ 99.09%
Net Profit Margin
-29.8K%
↓ 17613.61%
Q1 FY24Q/Q Change
Revenue
20.7K
↑ 4.14%
Net Income
-3.3M
↓ 44.05%
Net Profit Margin
-16.0K%
↑ 13774.21%
FY18Y/Y Change
Total Assets
1.5M
↓ 36.19%
Total Liabilities
733.6K
↓ 59.76%
FY19Y/Y Change
Total Assets
596.6K
↓ 59.24%
Total Liabilities
753.3K
↑ 2.68%
FY20Y/Y Change
Total Assets
260.3K
↓ 56.37%
Total Liabilities
1.1M
↑ 45.83%
FY21Y/Y Change
Total Assets
40.8M
↑ 15583.34%
Total Liabilities
30.6M
↑ 2687.72%
FY22Y/Y Change
Total Assets
37.1M
↓ 9.1%
Total Liabilities
2.5M
↓ 91.9%
FY23Y/Y Change
Total Assets
31.8M
↓ 14.19%
Total Liabilities
7.4M
↑ 198.03%
Q4 FY22Q/Q Change
Total Assets
37.1M
↓ 5.05%
Total Liabilities
2.5M
↓ 6.58%
Q1 FY23Q/Q Change
Total Assets
37.1M
↑ 0.0%
Total Liabilities
2.5M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
34.0M
↓ 8.25%
Total Liabilities
3.7M
↑ 47.16%
Q3 FY23Q/Q Change
Total Assets
33.9M
↓ 0.55%
Total Liabilities
6.2M
↑ 69.23%
Q4 FY23Q/Q Change
Total Assets
31.8M
↓ 5.96%
Total Liabilities
7.4M
↑ 19.67%
Q1 FY24Q/Q Change
Total Assets
29.8M
↓ 6.56%
Total Liabilities
7.1M
↓ 4.31%
FY18Y/Y Change
Operating Cash Flow
-1.0M
↑ 85.96%
Investing Cash Flow
-7.3K
↓ 85.18%
Financing Cash Flow
255.0K
↓ 89.54%
FY19Y/Y Change
Operating Cash Flow
-909.5K
↓ 9.88%
Investing Cash Flow
-13.1K
↑ 80.12%
Financing Cash Flow
55.0K
↓ 78.44%
FY20Y/Y Change
Operating Cash Flow
-499.6K
↓ 45.07%
Investing Cash Flow
-7.2K
↓ 44.74%
Financing Cash Flow
120.0K
↑ 118.31%
FY21Y/Y Change
Operating Cash Flow
-1.2M
↑ 150.22%
Investing Cash Flow
-180.5K
↑ 2392.3%
Financing Cash Flow
3.2M
↑ 2528.64%
Q4 FY22Q/Q Change
Operating Cash Flow
-1.2M
↑ 46.33%
Investing Cash Flow
1.2K
↓ 100.51%
Financing Cash Flow
1.4M
↓ 15.51%
Q1 FY23Q/Q Change
Operating Cash Flow
-615.4K
↓ 46.53%
Investing Cash Flow
1.2K
↑ 0.0%
Financing Cash Flow
-4.7K
↓ 100.33%
Q2 FY23Q/Q Change
Operating Cash Flow
-1.2M
↑ 87.02%
Investing Cash Flow
1.2K
↑ 0.0%
Financing Cash Flow
1.4M
↓ 29957.79%

Technicals Summary

Sell

Neutral

Buy

Ainos Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ainos Inc
Ainos Inc
-21.08%
-70.9%
-75.75%
-98.67%
-98.67%
Stryker Corporation
Stryker Corporation
4.27%
16.65%
22.1%
34.77%
82.03%
Boston Scientific Corp.
Boston Scientific Corp.
4.07%
37.85%
46.89%
79.63%
93.34%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
3.26%
27.0%
2.23%
-8.36%
51.45%
Abbott Laboratories
Abbott Laboratories
-2.62%
-2.21%
-0.86%
-5.87%
32.8%
Medtronic Plc
Medtronic Plc
0.44%
2.96%
-1.92%
-33.69%
-13.02%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ainos Inc
Ainos Inc
NA
NA
NA
0.0
-0.53
-0.25
NA
3.69
Stryker Corporation
Stryker Corporation
38.89
38.89
2.92
11.96
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
63.5
63.5
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
37.45
37.45
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
31.83
31.83
5.99
4.63
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
29.48
29.48
1.52
5.2
0.07
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ainos Inc
Ainos Inc
NA
$5.5M
-98.67%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$129.9B
82.03%
38.89
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$111.1B
93.34%
63.5
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$52.4B
51.45%
37.45
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$177.8B
32.8%
31.83
13.96%
Medtronic Plc
Medtronic Plc
Buy
$106.7B
-13.02%
29.48
11.36%

Institutional Holdings

  • TWO SIGMA SECURITIES, LLC

    0.41%

  • BlackRock Inc

    0.24%

  • Susquehanna International Group, LLP

    0.20%

  • UBS Group AG

    0.18%

  • Geode Capital Management, LLC

    0.16%

  • Tower Research Capital LLC

    0.03%

Company Information

Organization
Ainos Inc
Employees
46
CEO
Mr. Chun-Hsien Tsai
Industry
Miscellaneous

Discover More

FAQs